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Tractography patterns of subthalamic nucleus
deep brain stimulation
Nora Vanegas-Arroyave,1,! Peter M Lauro,2,! Ling Huang,2 Mark Hallett,3
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Deep brain stimulation therapy is an effective symptomatic treatment for Parkinson’s disease, yet the precise mechanisms respon-
sible for its therapeutic effects remain unclear. Although the targets of deep brain stimulation are grey matter structures, axonal
modulation is known to play an important role in deep brain stimulation’s therapeutic mechanism. Several white matter structures
in proximity to the subthalamic nucleus have been implicated in the clinical benefits of deep brain stimulation for Parkinson’s
disease. We assessed the connectivity patterns that characterize clinically beneficial electrodes in Parkinson’s disease patients, after
deep brain stimulation of the subthalamic nucleus. We evaluated 22 patients with Parkinson’s disease (11 females, age 57 " 9.1
years, disease duration 13.3 " 6.3 years) who received bilateral deep brain stimulation of the subthalamic nucleus at the National
Institutes of Health. During an initial electrode screening session, one month after deep brain stimulation implantation, the clinical
benefits of each contact were determined. The electrode was localized by coregistering preoperative magnetic resonance imaging
and postoperative computer tomography images and the volume of tissue activated was estimated from stimulation voltage and
impedance. Brain connectivity for the volume of tissue activated of deep brain stimulation contacts was assessed using probabilistic
tractography with diffusion-tensor data. Areas most frequently connected to clinically effective contacts included the thalamus,
substantia nigra, brainstem and superior frontal gyrus. A series of discriminant analyses demonstrated that the strength of con-
nectivity to the superior frontal gyrus and the thalamus were positively associated with clinical effectiveness. The connectivity
patterns observed in our study suggest that the modulation of white matter tracts directed to the superior frontal gyrus and the
thalamus is associated with favourable clinical outcomes and may contribute to the therapeutic effects of deep brain stimulation.
Our method can be further developed to reliably identify effective deep brain stimulation contacts and aid in the programming
process.
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Introduction
Deep brain stimulation (DBS) is an effective therapy for the
treatment of Parkinson’s disease and other neurological
conditions. Although clinically effective stimulation targets
such as the subthalamic nucleus (STN) and the globus pal-
lidus pars interna have been established (Wagle Shukla and
Okun, 2014), the precise mechanisms responsible for the
therapeutic effects of DBS remain unclear. While targets
consist of grey matter structures, DBS predominantly acti-
vates axons rather than cell bodies (McIntyre et al., 2004).
Therefore, white matter tracts near the deep nuclei may be
even more relevant.
A promising method, therefore, for understanding DBS is
diffusion tensor imaging (DTI). DTI is a MRI technique
that allows for non-invasive approximation of white
matter anatomical pathways, based on the diffusion of
water molecules through tissue (Pierpaoli and Basser,
1996; Jones, 2008). The use of this modality has recently
been implemented for the recognition of specific white
matter bundles associated with the clinical benefits of
DBS in movement disorders (Coenen et al., 2014;
Rozanski et al., 2014). In addition, DTI has been used to
identify specific white matter tracts associated with a fa-
vourable response of major depression to DBS (Riva-
Posse et al., 2014). These data raise the possibility that
optimal electrode implantation and stimulation parameter
selection for DBS may critically rely on the accurate iden-
tification of relevant white matter networks. However, trac-
tography studies in DBS for Parkinson’s disease have so far
been limited to the evaluation and targeting of specific
white matter tracts effective for tremor control (Coenen et
al., 2014).
Initial DBS programming sessions are often time consum-
ing, involving the screening of individual electrodes at pro-
gressively higher stimulation amplitudes to determine the
presence of both clinical benefits and side effects
(Volkmann et al., 2006). Thus, the success of DBS therapy
depends not only on an appropriate electrode placement
but also on the programmer’s expertise and the patient’s
ability to cooperate throughout an electrode screening ses-
sion. The characterization of clinically beneficial networks
using tractography provides a potential opportunity to fa-
cilitate the optimization of DBS programming through the
development of imaging-based electrode selection tools. In
addition, a better understanding of the specific neuronal
connectivity patterns associated with favourable clinical
outcomes in Parkinson’s disease patients treated with
DBS, could add to the knowledge of the basal ganglia
pathophysiology and the potential mechanisms of action
of DBS in Parkinson’s disease.
By using preoperative DTI-based tractography, we aimed
to characterize the specific stimulator-neuronal connectivity
associated with clinically effective contacts in patients with
Parkinson’s disease after STN DBS. We then assessed if the
strength of association with areas of relevant connectivity
was indicative of clinical effectiveness.
Materials and methods
Subjects
Twenty-two patients with idiopathic Parkinson’s disease who
received bilateral STN DBS surgery at the National Institutes
of Health between 2011 and 2014 were included in the study,
on a consecutive basis. All patients were assessed by a move-
ment disorders neurologist and met United Kingdom
Parkinson’s Disease Society Brain Bank Criteria for the diag-
nosis of idiopathic Parkinson’s disease (Hughes et al., 1992)
and Core Assessment Program for Surgical Interventional
Therapies criteria for the surgical treatment of Parkinson’s dis-
ease (Defer et al., 1999). Patients underwent preoperative DBS
screening including brain MRI, neurological examination,
complete Unified Parkinson’s Disease Rating Scale (UPDRS)
with motor part III scoring in the OFF and ON medication
states, and neuropsychological evaluation. This study was con-
ducted under National Institutes of Health Institutional
Review Board-approved protocols, and informed consent was
obtained from all patients.
Surgical procedure
Based on the Schaltenbrand–Wahren atlas, indirect targeting
coordinates were determined 3 mm posterior to the midcom-
missural point, 12 mm lateral and 5 mm inferior to the mid-
commisural line, corresponding to the ventral border of the
STN. Direct targeting was then performed by visualization of
the STN on preoperative MRI (coregistered T1- and T2-
weighted MRI to CT images using Stealth Station i7,
Medtronic) and intraoperatively using microelectrode record-
ings. All patients underwent DBS surgery after an overnight
medication withdrawal (12 h after the last dose of dopamin-
ergic medication). Three tungsten microelectrodes were in-
serted simultaneously for target localization. Final trajectory
and depth of lead placement were selected using intraoperative
electrophysiology and test stimulation. All patients were im-
planted with DBS Lead Model 3389 (Medtronic).
Deep brain stimulation programming
and patient follow-up
One month after implantation of the DBS leads, all patients
underwent an initial programming session performed by a
movement disorders neurologist, in the OFF medication state
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(Volkmann et al., 2006). Monopolar screening was performed
for each of the four contacts on each lead. The stimulation
amplitude was gradually increased to determine the limits of
each contact’s therapeutic window, at predetermined pulse
width and frequency. All monopolar screening was performed
with pulse width set at 60 ms while stimulation frequency
ranged from 130 to 160 Hz depending on the presence and
predominance of tremor. Window entry was defined as the
voltage where clinical benefit was first observed for each pa-
tient’s predominant parkinsonian signs (tremor, rigidity or bra-
dykinesia). Window exit was defined as the voltage where side
effects occurred (or as 6.0 V if no side effects were observed).
The window size was determined by subtracting the window
entry from the window exit.
As previously described by others (Volkmann et al., 2006),
the contact with the largest therapeutic window was selected
as the stimulating contact for chronic stimulation. In cases
where two or more contacts demonstrated similarly large
therapeutic windows, the stimulating contact was chosen arbi-
trarily based on the magnitude of clinical improvement
observed during examination. Contacts with a therapeutic
window but not selected for chronic stimulation, were con-
sidered as potential contacts. If no therapeutic window was
identified on any of the four lead contacts, patients were pro-
grammed on a bipolar configuration. For patients whose par-
kinsonian signs in the less affected side were not consistent to
establish a therapeutic window, only the threshold for side
effects was targeted. Individual DBS lead therapeutic imped-
ances were recorded for the stimulating contact after the final
setting was determined.
Follow-up visits at 3 and 6 months postoperatively included
neurological examination, programming optimization and
UPDRS scoring in the ON medication–on stimulation states.
A complete record of the patient’s dopaminergic medication
regimen was also obtained at each visit and converted to a
standard value of levodopa equivalent daily dose (Tomlinson
et al., 2010).
Electrode discrimination
According to the therapeutic window obtained during the ini-
tial programming session, contacts were discriminated based
on the observed clinical effectiveness in monopolar stimula-
tion. All contacts with a therapeutic window were defined as
clinically effective contacts. This group included stimulating
contacts and potential contacts (Fig. 1). Contacts without a
therapeutic window, causing exclusively side effects, were
defined as non-effective contacts. This group included contacts
that did not demonstrate clinical benefits during the initial
programming session.
Image processing and tractography
estimation
Image acquisition
All patients underwent preoperative MRI on a 3.0 T scanner
(Philips Achieva XT) 1 day before surgery, in the ON medica-
tion state. Preoperative MRI included T1-weighted turbo field
echo, T2-weighted turbo spin echo and high-angle echo planar
diffusion weighted image sequences. The diffusion weighted
image sequences were acquired with the following parameters:
repetition time: 9776.51 ms, echo time: 65 ms, slice thickness:
2.00 mm, spacing between slices: 2.00 mm, echo train length:
59, field of view: 224 mm2 (in-plane resolution 2.0 #
2.0 mm2), flip angle: 90$, acquisition matrix: 112 # 112 with
78 axial locations, b = 1000 s/mm2, 1 b0 volume, 32 non-collin-
ear gradient directions, and total acquisition time: 6 min 48 s.
Postoperative imaging included T1-weighted fast-field-echo
MRI at 1.5 T (Philips Achieva XT) and head CT (Siemens
SOMATOM), within 3 to 7 days after surgery.
Image processing
Our data were processed using DBSproc, an open source pipe-
line for DBS electrode localization and tractographic analysis,
available in the Analysis of Functional NeuroImages (AFNI)
distribution (Lauro et al., 2016). Briefly, the anterior and pos-
terior commissure landmarks were manually defined on the
T2-weighted preoperative volume using the Medical Image
Processing, Analyzing and Visualization software package
(McAuliffe et al., 2001; Bazin et al., 2007); http://mipav.cit.
nih.gov. All volumes were rigid body transformed to create a
horizontal anterior commissure–posterior commissure line and
a vertical midsagittal plane with the anterior commissure as its
origin.
Diffusion images were motion-, eddy-, and echo-planar ima-
ging distortion-corrected, and registered to the anterior commis-
sure-posterior commissure aligned T2-weighted volume using
standard tools within the TORTOISE software package
(Pierpaoli et al., 2010); https://science.nichd.nih.gov/confluence/
display/nihpd/TORTOISE. Diffusion tensors and their asso-
ciated parameters (fractional anisotropy, principal directions,
eigen values) were estimated non-linearly from TORTOISE-pro-
cessed diffusion data using Functional and Tractographic
Connectivity Analysis Toolbox (FATCAT) (Taylor and Saad,
2013), within AFNI (Cox, 1996); http://afni.nimh.nih.gov.
Uncertainty within fractional anisotropy and principal direction
datasets, necessary for probabilistic tractography, was also cal-
culated for probabilistic tractography using 500 jackknife-
resampling iterations.
As part of DBSproc, preoperative MRI, postoperative MRI
and CT images were first registered to patient-specific DTI
space by executing the @DBSproc1 script. Quality control of
image registrations was performed by visual inspection. DBS
leads were then automatically identified from CT volume and
contacts were localized using @DBSproc2. Specifically, lead
volumes were reconstructed using SUMA software (Saad and
Reynolds, 2012); http://afni.nimh.nih.gov, based on their topo-
logical characteristics. Electrode centroid coordinates were
automatically calculated from predefined tip to contact dis-
tances and their locations were then evaluated in relation to
the central mass of the STN. The STN was defined for each
subject using the Talairach-Tournoux atlas included in the
AFNI distribution.
Grey matter regions of interest for tractography analysis
were segmented from DTI-registered preoperative T1-weighted
volumes with the FreeSurfer software package (Fischl, 2012);
http://surfer.nmr.mgh.harvard.edu. We used the ‘aparc + aseg’
atlas from each patient’s segmentation data, which contained
89 grey matter regions of interest. We used the Talairach-
Tournoux atlas to define additional deep nuclei regions of
interest within the labelled ventral diencephalon. Specific sub-
nuclei added to the segmented brain included the red nucleus,
substantia nigra, STN and hypothalamus. Specifically, each
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patient’s preoperative T1-weighted volume was non-linearly
registered to the standard Talairach space. The resultant trans-
formations were inverted and applied to the selected regions of
interest in the standard space to bring regions of interest to
patient-specific space. All regions of interest were inflated to
the neighbouring voxels including faces and edges, with a stop
criterion at neighbour regions of interest or fractional anisot-
ropy 40.2.
Tractography estimation
The volume of tissue activated (VTA) was used to represent
each contact’s effective stimulation volume as a region of inter-
est. VTA was estimated as a sphere centred at the contact’s
centroid coordinate with its radius calculated from individual
lead impedance and window entry voltage (Mädler and
Coenen, 2012). Probabilistic tractography was used to deter-
mine the number of tracts from each VTA, at entry voltage, to
grey matter regions of interest using FATCAT (Taylor and
Saad, 2013). Default tracking parameters were used (fractional
anisotropy 40.2, turning angle 560$, keeping tracts with
length 420 mm, eight seeds per voxel) with 5000 Monte
Carlo iterations. To normalize for differences in voltage and
VTA volume, we expressed connectivity strength as a fraction




To characterize the connectivity of all clinically effective con-
tacts (stimulating contacts and potential contacts), we per-
formed a group analysis to determine the brain regions
frequently associated with effective stimulation. Tracts from
each clinically effective contact were converted to binary
values for each brain region of interest. A value of 1 was
assigned for the presence of connectivity from a contact’s
VTA to a brain region of interest (a threshold of tracts
41% of all the streamlines from the VTA was used) and a
value of 0 was assigned for the absence of tracts (51% of
total streamlines). Thus, the frequency of connectivity across
all clinically effective contacts was obtained from the binarized
results for each region of interest. Subcortical regions with
frequencies of connectivity 40.85 and cortical regions with
frequencies of connectivity 40.5 were considered relevant. A
lower threshold was used to select relevant ipsilateral cortical
areas given the limitations of DTI at delineating long-range
anatomical connections and specifically superficial cortical pro-
jections (Reveley et al., 2015).
Individual lead analysis
The most frequently connected regions of interest from the
group analysis were selected for post hoc within-lead discrim-
inant analyses. Leads that had exclusively clinically effective
contacts were not included. We assessed whether connectivity
strength to each of these relevant regions could be an indicator
of clinical effectiveness. Specifically, for each of these regions
of interest, we tested the hypothesis that the electrode with the
strongest connectivity within each lead is a clinically effective
contact. We defined the discriminant power as the positive
predictive value of each region of interest.
For regions found to be positively associated with clinical
effectiveness, we then assessed whether the connectivity
strength of the clinically effective contacts was higher than
that of the non-effective contacts. See statistical analysis.
Statistical analysis
Demographic and clinical data were examined for normality
(Shapiro-Wilk test). Normally distributed data were analysed
with parametric tests (paired t-test); non-normally distributed
data were analysed with non-parametric tests (paired
Wilcoxon rank-sum test).
We performed within-lead discriminant analyses to investi-
gate the association between clinical effectiveness and contact
strength of connectivity to relevant regions. For this purpose,
we tested the alternative hypothesis that identifying clinically
effective contacts based on their strength of connectivity was
better than chance. We evaluated the statistical significance
with a Poisson binomial test with chance probabilities for
the trials (each lead was a trial; chance probability of success
for lead that has three non-effective contacts is 0.25, that of
lead that has two non-effective contacts is 0.5 and that of lead
that has one non-effective contact is 0.75). Furthermore, an
odds ratio (OR) was obtained for each region of interest,
using electrode connectivity strength as a measure of exposure
and clinical effectiveness or ineffectiveness as the outcome.
Figure 1 Electrode discrimination. The electrode discriminations of three individual leads (A–C) are displayed for illustration purposes.
Contacts were classified as stimulating contact (SC), potential contact (PC) or non-effective (NE) contact, based on their therapeutic window
sizes. The y-axis represents the voltage of monopolar stimulation at the initial programming session. x-axis label represents each contact on
monopolar stimulation. Grey = no clinical effect was observed; cyan = therapeutic window between window entry and window exit voltages;
orange = voltage above window exit, once side effects were observed.
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For each lead included in the above analysis, we averaged
the connectivity strength of all clinically effective contacts and
compared it with that of non-effective contacts. A paired
Wilcoxon rank-sum test was used given the variability of con-
nectivity strength across subjects. All calculations were per-
formed using SPSS! (Version 20; Chicago, IL, USA).
Results
General clinical outcomes
Twenty-two patients (11 females, age 57 " 9.1 years, dis-
ease duration 13.3 " 6.3 years) with idiopathic
Parkinson’s disease who underwent bilateral STN DBS sur-
gery at the National Institutes of Health were included in
this study. Clinical characteristics at baseline, 3 and 6
months postoperatively are described in Table 1. There
were no significant changes in UPDRS part II at 3 and 6
months. Similarly, comparisons between preoperative ON
medication and postoperative ON medication–on stimula-
tion UPDRS part III at 3 and 6 months demonstrated no
statistically significant changes. All patients demonstrated a
significant improvement of the UPDRS part IV and a sig-
nificant reduction of the total requirement of dopaminergic
medications expressed as levodopa equivalent daily dose at
3 and 6 months postoperatively.
Postoperative stereotactic stimulator tip coordinates in
reference to the mid-commissural point were x = 9.7 "
1.3 [mean " standard deviation (SD)] lateral, y = 4.3 "
2.5 posterior and z = 6.5 " 1.7 inferior, for the left hemi-
sphere and x = 11.1 " 1.2 lateral, y = 3.7 " 2.5 posterior
and z = 6.3 " 1.8 inferior for the right hemisphere.
Electrode discrimination
Twenty-two patients with bilateral STN DBS, for a total of
44 DBS leads were screened at the initial programming
sessions. Four leads where the contralateral parkinsonian
signs were not consistent to establish a therapeutic
window were excluded from the electrode discrimination.
In addition, due to the inability to precisely model a bipolar
VTA, two leads without clinical benefits on monopolar
screening were excluded.
Thus, a total of 152 contacts (38 DBS leads) were dis-
criminated. One hundred and twenty-three contacts were
classified as clinically effective contacts. Twenty-nine con-
tacts were classified as non-effective contacts.
Group analysis
Based on the analysis of contact connectivity to grey matter
regions of interest described in the ‘Connectivity analysis’
section, we identified the cortical and subcortical regions
most frequently associated with the 123 clinically effective
contacts (Fig. 2).
Most clinically effective contacts demonstrated connectiv-
ity to the brainstem (0.98) and thalamus (0.96), followed
by the STN (0.93) and substantia nigra (0.86). Among cor-
tical regions, the superior frontal gyrus demonstrated the
highest frequency of connectivity (0.56) across clinically
effective contacts.
Individual lead analysis
For the above areas, we performed within-lead discriminant
analyses to assess whether connectivity strength was asso-
ciated with clinical effectiveness. STN was excluded as
connectivity to the surgical target was considered simply
an indicator of electrode location. The region of interest’s
discriminant power was expressed as a proportion of the
leads (n = 20) on which the electrode with the strongest con-
nectivity to the region of interest was a clinically effective
contact. As shown in Table 2, strong connectivity to the
superior frontal gyrus and the thalamus were positively asso-
ciated with clinical effectiveness. The superior frontal gyrus
demonstrated significantly higher discriminant power
[OR = 6.4, 95% confidence interval (CI): 1.3–30.6,
P = 0.014] while no significant effect was observed for the
thalamus (OR = 2.9, 95% CI: 0.9–9.6, P = 0.08). Based on
these findings, we further evaluated the differences on aver-
age connectivity strength between effective and non-effective
contacts. A paired Wilcoxon rank-sum test demonstrated a
significantly higher connectivity of the effective contacts to
both regions (Fig. 3). For the superior frontal gyrus the
average values of connectivity strength [mean " standard
error of the mean (SEM)] were 0.05 " 0.06 for clinically
effective contacts and 0.04 " 0.06 for non-effective contacts
(P = 0.0038). Those for the thalamus were 0.21 " 0.10 and
0.18 " 0.10 (P = 0.034), respectively. An individual lead ex-
ample is displayed in Fig. 4.
Electrode location in reference to the
subthalamic nucleus centre
Individual contact localizations for all clinically effective
contacts were determined in relation to the STN centre of
mass, based on the Talairach template. Average coordinates
were x = 2.0 " 2.2 (mean in mm " SD) lateral, y = 1.8 "
1.4 anterior and z = 0.5 " 2.4 inferior, for the left hemi-
sphere and x = 1.7 " 1.4 lateral, y = 1.1 " 1.5 anterior and
z = 1.4 " 2.5 superior, for the right hemisphere. The loca-
tion of clinically effective contacts in relation to the STN
centre is represented in Fig. 5 and Supplementary Fig. 1,
using AFNI’s Talairach-Tournoux atlas for STN axial rep-
resentation and SUMA for contact surfaces.
Discussion
Our study aimed to establish the specific connectivity pat-
terns that characterize clinically beneficial electrodes in pa-
tients with Parkinson’s disease treated with STN DBS, using
probabilistic tractography. We implemented a novel ap-
proach that allowed both a group and a within-lead
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tractographic characterization of electrodes with clinically
beneficial profiles for the treatment of Parkinson’s disease.
The results of this study suggest that clinically effective con-
tacts have a relevant interaction with white matter structures
connected to the superior frontal gyrus and the thalamus.
Early views maintained that DBS inhibited STN neurons
(Beurrier et al., 2001; Filali et al., 2004). This concept then
extended to the idea that stimulation suppressed the exagger-
ated beta oscillatory synchronization observed in the basal
ganglia of patients with Parkinson’s disease (Kühn et al.,
2008). Further evidence obtained from electrophysiological
studies suggests that high frequency stimulation decouples
neuronal somatic and axonal activity, simultaneously inhibit-
ing cell bodies while generating orthodromic and antidromic
axonal action potentials (Johnson and McIntyre, 2008).
Therefore, DBS appears to introduce a more regular axonal
firing pattern in the parkinsonian basal ganglia (Garcia et al.,
2005; Johnson and McIntyre, 2008; Dorval et al., 2010).
The STN is a small nucleus connected with other basal
ganglia and several cortical regions. Based on the topog-
raphy of its cortico-subthalamic projections, the STN has
been subdivided into motor, limbic and associative func-
tional regions (Haynes and Haber, 2013). This nucleus is
surrounded by dense bundles of white matter fibres such as
the pallidothalamic fibres originating in the globus pallidus
pars interna. These pallidal fibres include the ansa lenticu-
laris and the lenticular fasciculus (Hassler, 1974; Voges et
al., 2002) (Fig. 6). The lenticular fasciculus and the zona
incerta separate the dorsal STN from the caudal aspect of
the thalamus (Hamani et al., 2004). The possibility of
Figure 2 Frequency of connectivity histogram. The y-axis represents frequency of connectivity across all clinically effective contacts. The
x-axis represents each grey matter region of interest (ROI). For subcortical areas, most clinically effective contacts demonstrated consistent
connectivity to the brainstem, thalamus, the subthalamic nucleus and the substantia nigra. A frequency threshold of 0.85, represented by the black
dotted line, was used for subcortical regions. Among cortical regions, the superior frontal gyrus demonstrated a frequency of connectivity higher
than 0.5 across all clinically effective contacts. A frequency threshold of 0.5, represented by the grey dotted line, was used for cortical regions.
Table 1 Comparisons between baseline and clinical outcomes at 3 and 6 months postoperatively
Baseline 3 months 6 months
UPDRS I 2.9 (2.8) 1.5 (1.3)! 2.9 (2.5)
UPDRS II 9.2 (9.4) 9.4 (6.3) 9.6 (5)
UPDRS III ON medication 19.9 (7) 19.2 (5.9) 19.5 (6.7)
UPDRS IV 8.8 (3.6) 3.2 (1.8)!! 3.1 (2.4)!!!
LEDD 1059 (466) 412 (293)!! 398 (253)!!!
Data are presented as mean (SD). P-values were calculated using a paired Wilcoxon rank-sum test.
!P = 0.019; baseline versus 3 months postoperatively.
!!P 5 0.0001; baseline versus 3 months postoperatively.
!!!P 5 0.0001; baseline versus 6 months postoperatively. LEDD = levodopa equivalent daily dose.
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direct electric field influences on those neighboring struc-
tures and a contribution to the clinical effects of STN DBS
has been postulated (Patel et al., 2003; Plaha et al., 2006).
Plaha et al. specifically targeted the STN, the caudal zona
incerta and the pallidofugal fibres dorsomedial to the STN
(Plaha et al., 2006), demonstrating that stimulation of the
zona incerta resulted in a greater improvement of motor
scores than stimulation within the STN. In addition, the
benefits for various tremor types, including Parkinsonian
tremor, have been demonstrated with direct targeting of
Figure 3 Connectivity strength of effective and non-effective contacts to the superior frontal gyrus and the thalamus.
Connectivity strength is expressed as a fraction of the total contact connectivity (A and B). Error bars represent the standard error of the mean.
For the superior frontal gyrus (A) the average values of connectivity strength were 0.05 " 0.06 for clinically effective contacts and 0.04 " 0.06
for non-effective contacts (P = 0.0038). Those for the thalamus (B) were 0.21 " 0.10 and 0.18 " 0.10 (P = 0.034), respectively. P-values were
calculated from paired Wilcoxon rank-sum tests to account for the observed variability in connectivity strength across subjects. (C and D) The
differences on connectivity strength between effective and non-effective contacts for the superior frontal gyrus and the thalamus, respectively. !!P
5 0.005; !P 5 0.05.
Table 2 Association between region of interest connectivity strength and clinical effectiveness
Region of interest Discriminant power By chance probability P-value OR (95% CI)
Superior frontal gyrus (n = 18) 0.89 0.64 0.014! 6.4 (1.3–30.6)
Thalamus (n = 20) 0.80 0.64 0.085 2.9 (0.9–9.6)
Substantia nigra (n = 19) 0.58 0.64 0.813 0.69 (0.2–2.0)
Brainstem (n = 20) 0.45 0.64 0.979 0.35 (0.1–1.0)
Discriminant power was defined as a proportion of trials that successfully identified a contact with clinical efficacy, by selecting the contact with the highest connectivity to each
relevant region of interest, within each lead. n represents the number of leads included in the analysis; leads without connectivity to the region of interest were excluded. Significance
defined as !P 5 0.05. P-value was obtained by testing the null hypothesis that contacts identified by the discriminant analysis were selected by chance. The null distribution was
Poisson binomial with success probabilities of either 0.75, 0.5 or 0.25, depending on the proportion of effective contacts in a lead. OR of association using electrode connectivity
strength as a measure of exposure and clinical effectiveness or ineffectiveness as the outcome.
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the dentato-rubro-thalamic tract in close proximity to the
STN (Mädler and Coenen, 2012; Coenen et al., 2014).
More recently, cortico-subthalamic projections have
emerged as an important contributor to the pathophysi-
ology of Parkinson’s disease and as a potential neuromo-
dulation target (Li et al., 2014).
The connectivity patterns and the location of clinically
effective electrodes described in our study further suggest
that besides STN stimulation, the modulation of surround-
ing white matter tracts and cortico-subthalamic projections
may play a role in the mechanism of action of this type of
therapy. The observed connectivity patterns could corres-
pond to the dentato-rubro-thalamic tract, zona incerta and/
or pallidothalamic tract directed towards the thalamus.
More importantly, this complex region encompasses cor-
tico-subthalamic projections such as the hyperdirect path-
way, for which motor components originate in M1 and
Brodmann area 6 (Haynes and Haber, 2013). Our results
reveal a higher connectivity of clinically effective contacts
with the superior frontal gyrus, which contains the dorsal
and anterior areas of Brodmann area 6. Those descending
motor and premotor cortical projections enter the STN in
its dorsal aspect after branching off from the internal cap-
sule (Li et al., 2013). The interruption of those cortico-
subthalamic interactions using anti-NMDA (N-methyl D-
aspartate) receptors has demonstrated motor benefits in
animal models (Pan et al., 2014). In parkinsonian rats,
STN DBS has been shown to elicit antidromic activation
and to suppress pathological oscillatory activity in cortical
layers (Li et al., 2012). Electrical stimulation of these pro-
jections may therefore result in similar motor effects in
humans. In fact, using subdural electrodes over the tracto-
graphically defined origin of the hyperdirect pathway, one
study demonstrated attenuation of beta hypersynchrony by
STN DBS (Whitmer et al., 2012). The high discriminant
powers of the superior frontal gyrus and the thalamus ob-
tained in our study, further support their role on the mech-
anism of action of DBS and could serve as the basis for
future development of imaging-based programming
interfaces.
The analysis presented in our study was based on the
specific connectivity patterns observed in a Parkinson’s dis-
ease population with conventional clinical outcomes after
STN DBS. DBS therapy has demonstrated significant incre-
ments in several clinical measures. However, comparisons
between preoperative ON medication and postoperative
ON medication-on stimulation states typically do not dem-
onstrate differences as it could be subject to ceiling effects
(Weaver et al., 2009; Moro et al., 2010). Instead, the main
measure of success is the increase in time ON without dys-
kinesia and the reduction in motor fluctuations overall.
Therefore, although there were no significant differences
Figure 4 Tractographic patterns of DBS electrodes on a single lead. Figure illustrates the different tractographic patterns of all contacts
on a single DBS lead. Window entry voltages were used to calculate VTA sizes. (A and B) The tractographic patterns of two non-effective (NE)
contacts (c8 and c9). (C and D) Two clinically effective contacts [c10: stimulating contact (SC) and c11: potential contact (PC)]. For each contact,
tracts passing through the corresponding red sphere (representing the contact’s VTA) are displayed. Tracts were obtained from mini probabilistic
tractography with 20 iterations. Colours represent different region of interest-VTA bundles in SUMA Software. A = anterior; P = posterior.
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between preoperative ON medication and postoperative
ON medication–on stimulation states in our patient popu-
lation, significant clinical benefits were reflected in the large
reductions in UPDRS part IV and the levodopa equivalent
daily dose.
Although accounting for impedance and specific voltage
magnitudes, our simplified method of spherical VTA esti-
mation does not consider the specific conductivity proper-
ties of individualized grey and white matter tissues (Butson
et al., 2007). By using this simplified method, entry voltage
differences between contacts could have resulted in larger
VTA radii. Voltage differences could then result in larger
numbers of tracts in association with a proportionally
larger VTA. We therefore represented our tractography
data as a fraction of the number of tracts associated with
the VTA to normalize for voltage differences between con-
tacts. Additionally, although tractography may be limited
by data resolution and resulting anatomical accuracy, our
method up-sampled the DTI data to 1.5 mm during pro-
cessing to improve registration. Furthermore, we used post-
operative T1 MPRAGE (magnetization-prepared rapid
gradient echo) images (1.0 mm isotropic), coregistered
with CT images for proper contact localization (Lauro et
al., 2016). We were able to demonstrate differential pat-
terns of connectivity exhibited by contacts in the same lead
(Supplementary Fig. 2).
As our tractography results were based on preoperative
DTI, it is possible that brain connectivity patterns change
postoperatively due to cell death, brain shift, or any other
factors attributable to the surgical procedure. Moreover, a
single impedance measurement was only obtained for the
final stimulating settings and it does not account for the
postoperative impedance variability over time (Lungu et al.,
2014). On the other hand, STN localization has shown to
vary across methodologies, a problem further complicated
by the variability of STN locations in different age groups
(Sánchez Castro et al., 2005; Keuken et al., 2013).
Therefore, a more comprehensive look into electrode loca-
tions in relation to the STN would likely require individua-
lized STN delineation.
The relationship between functional markers observed in
PET and functional MRI studies with tractography patterns
in patients undergoing DBS therapy has not yet been deter-
mined (Hilker et al., 2004; Min et al., 2012, 2014; Park et
al., 2014). Therefore, although DTI provides information
regarding tract orientation and potential connectivity with
grey matter structures, the lack of association with specific
areas does not necessarily translate into the lack of neur-
onal connectivity or functional interactions. Nevertheless, it
has been suggested that structural connectivity is an indir-
ect reflection of potential functional association (Torres et
al., 2014) and by using preoperative DTI and postoperative
imaging coregistration, we were able to determine specific
Figure 6 Subthalamic nucleus and surrounding structures.
Schematic representation of the STN and surrounding structures.
Pallidothalamic fibres originated in the internal segment of the
globus pallidus pars interna include the ansa lenticularis (AL) and the
lenticular fasciculus (LF). The ansa lenticularis courses medial and
ventral to the STN to reach the Fields of Forel and then divides into
the thalamic fascicle and descending projections to the midbrain.
The lenticular fasciculus originates in the medial aspect of the globus
pallidus pars interna, perforates the IC and passes through the
ventral surface of the zona incerta (ZI). A portion of the lenticular
fasciculus and the zona incerta separate the dorsal STN from the
ventral thalamus. GPe = globus pallidus pars externa; IC = internal
capsule; PPN = pedunculopontine nucleus; SN = substantia nigra.
Figure 5 Electrode locations in reference to the subthalamic nucleus. Location of clinically effective contacts is illustrated in relation to
the subthalamic nucleus (yellow surface). Contacts are represented as 2 mm spheres (blue circles) back-transformed from the subject native space
to the Talairach-Tournoux space. Location data are overlaid on five consecutive axial slices.
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connectivity patterns that characterize more clinically ef-
fective DBS electrodes.
As a result of the emergence of new technologies with
large electrode arrays, traditional electrode screening meth-
ods may not be feasible. Our approach adds to the current
efforts (Pourfar et al., 2015) on the development of pre-
operative imaging and programming interfaces for DBS in
Parkinson’s disease. However, large and randomized stu-
dies will be necessary in the future.
Our results suggest that the modulation of white matter
tracts connected to the superior frontal gyrus and the thal-
amus play an important role in the mechanism of action of
STN DBS for Parkinson’s disease. The high association be-
tween superior frontal structures and clinically effective
contacts suggests the benefits of modulating cortico-
subthalamic pathways in the management of Parkinson’s
disease. Our study suggests that high connectivities to the
superior frontal gyrus and the thalamus are indicators of
clinical effectiveness, and the observed discriminant power
of these two areas could serve as basis for the development
of preoperative imaging-based programming interfaces for
DBS in Parkinson’s disease. Future directions include the
integration of additional quantitative measures and further
refinements of the method.
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